On November 21-22, 2023, the 177th meeting of the European Pharmacopoeia Commission (EPC) was held in Strasbourg, France, in which Natalia VOLOVYK, Deputy Director for Quality of the Ukrainian Scientific Pharmacopoeia Center for the Quality of Medicinal Products participated via videoconference.
On December 14th, an online webinar was hosted by the European Directorate for the Quality of Medicines & HealthCare (EDQM) to introduce the new Ph. Eur. Cannabis Flower Monograph (3028). This event was attended by Elina KOTOVA, Head of the Department of Experimental Support for the Development of Monographs on Herbal Drugs at the Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines, and her colleague…
Dmytro LEONTIEV and Natalia VOLOVYK, Deputy Director for Science and Deputy Director for Quality, respectively, at the Ukrainian Scientific Pharmacopeial Center for Quality of Medicines, took part in the AQbD Symposium organised by Waters Corporation.
The European Pharmacopoeia Commission (EPC) has recently included the Egyptian Drug Authority as an observer. This inclusion reflects the growing influence and dynamic nature of the European Pharmacopoeia (Ph. Eur.), which now boasts 33 global observers, alongside its 39 European member countries and the European Union as signatory parties.
On November 23rd, 2023, the British Pharmacopoeia Commission held a webinar on ATMP Guidance, featuring Clare BLUE, Senior CMC Translation Consultant at eXmoor Pharma, Ryan SMITH, British Pharmacopoeia Specialist at the Medicines and Healthcare products Regulatory Agency, and Lily LI, Lead Scientist of Analytical Development at AviadoBio. Nelia KYSHYNETS, a Senior Researcher from the Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines, participated in this…
On November 22-23, 2023, in Strasbourg, France, the 75th meeting of the Committee of Experts on the Classification of Medicines as regards their supply (CD-P-PH/PHO), which operates under the European Directorate for the Quality of Medicines & HealthCare (EDQM), took place. Ukraine was represented at the meeting by Natalia Volovyk, the Deputy Director for Quality of the Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines,…
The team of the Ukrainian Scientific Pharmacopeial Center for Quality of Medicines congratulates Dmytro LEONTIEV on his 60th birthday!
On November 30, 2023, in Kyiv, the Pharmaceutical Forum "PHARMEXPERT 2023" took place, dedicated to the discussion of the creation of a single National Regulatory Authority in the pharmaceutical sector of Ukraine (NRA) — a central executive body with a special status that implements state policy in the field of development, market authorisation, quality control, safety, and efficacy of medicines, as stipulated by the Law…
On November 13th, 2023, the US Pharmacopoeia (USP) hosted an insightful 3-hour online event titled “Conversation with USP: Approaches to Developing and Revising General Chapters”. This event featured key speakers and participants from various international pharmaceutical entities, including the Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines, represented by Olga Tymchenko, Yulia Merkulova, Nelya Kyshynets, and Natalia Volovyk.
The 2nd HPTLC Online User Meeting 2023, titled “HPTLC 4.0 – Awakening the Giant”, was successfully held on June 20th, 2023. This insightful event, organized by the International HPTLC Association, featured participation from Tetiana YURCHENKO and Elina KOTOVA of the Department of Experimental Support for the Development of Monographs on Herbal Drugs at the Ukrainian Scientific Pharmacopoeial Center for Quality of Medicines.
On November 9, 2023, an event dedicated to the World Science Day for Peace and Development took place in Kharkiv. It was organized on the initiative of the Kharkiv Regional Military Administration and the Northeast Scientific Center of the National Academy of Sciences and the Ministry of Education and Science of Ukraine.
The Japanese Pharmacopoeia (JP) and the United States Pharmacopeia (USP) unveiled a new pilot project aimed at advancing the forward-looking harmonization of pharmacopoeial standards for pharmaceutical substances and medicinal products.
